LLC Insight Holdings Group Sells Shares of Hinge Health

LLC Insight Holdings Group sold 224,399 shares of Hinge Health, Inc. on June 22, 2026.

Editorial illustration for Hinge Health, Inc. (HNGE)

Key Points

  • LLC Insight Holdings Group sold 224,399 shares of Hinge Health, Inc. on June 22, 2026.
  • Hinge Health trades on the NYSE under the ticker HNGE and closed at $70.38 on Thursday.
  • Wells Fargo maintained a buy rating with a $90 target for Hinge Health on June 24, 2026.

Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.

LLC Insight Holdings Group recently sold 224,399 shares of Hinge Health, Inc. (NYSE:HNGE) on June 22, 2026. The stock was trading at $70.38 on Thursday.

Insider Buying and Selling at Hinge Health, Inc.

Insight Holdings Group LLC has been active, selling 224,399 shares on June 22, 2026. Additional transactions included the sale of 112,477 shares on June 23, 2026, at an average price of $70.21, with some trades planned under a Rule 10b5-1 plan.

Other Institutional Activity in Hinge Health

In other institutional activity, Insight Holdings Group, LLC held its position steady with 9,375,164 shares valued at approximately $361.5 million. 11.2 Capital Management, LLC also maintained its stake with 3,704,524 shares worth about $142.8 million. Deer Management Co. LLC opened a new position with 2,633,707 shares valued at $101.6 million. Bit Capital GmbH reduced its holdings by 1,006,304 shares, ending with 2,309,797 shares valued at around $89.1 million, a 30.3% decrease. RTW Investments, LP significantly increased its position by 1,576,500 shares, holding a total of 1,930,000 shares valued at $74.4 million, marking a 446.0% increase.

Hinge Health, Inc. Stock Down 19.2%

Shares of Hinge Health traded at $70.38 on Thursday. The company has a market cap of approximately $5.33 billion and a forward P/E ratio of 20.59. Its 52-week range is between $30.08 and $71.43, with a 50-day moving average of $52.90 and a 200-day moving average of $47.85. The company has a current ratio of 1.30, a quick ratio of 1.04, and a debt-to-equity ratio of 2.24.

Year to date

$HNGE stock price

Daily closing prices, year to date. Not investment advice.

Recent Earnings

Hinge Health reported revenue of $646.3 million, showing a growth rate of 47.2%. However, the company posted a net margin of -78.95% and a return on equity of -136.00%. The next earnings report is expected on August 4, 2026.

Analysts Set New Price Targets

On June 24, 2026, Wells Fargo maintained its buy rating on Hinge Health with a price target of $90. Baird kept a hold rating with a $65 target on June 17, 2026. Raymond James and Canaccord Genuity also maintained buy ratings with targets of $80 and $76, respectively, on June 15, 2026. Overall, the consensus is a buy, with an average target price of $79.73 based on 15 analyst opinions.

About Hinge Health, Inc.

Hinge Health, Inc., headquartered in San Francisco, California, focuses on using technology to scale and automate musculoskeletal (MSK) care. It offers solutions for acute injuries, chronic pain, and post-surgical rehabilitation through AI-powered motion tracking and a proprietary electrical nerve stimulation device. Founded in 2012, Hinge Health primarily serves self-insured employers and operates in the health information services sector.

Bottom Line

LLC Insight Holdings Group's recent sale of Hinge Health shares is part of ongoing insider activity. While the stock's performance has been strong, analysts maintain a generally positive outlook. Investors keep a close watch on insider transactions like these as part of their broader strategy. Note that this information reflects past activity and may not represent current holdings.

Get Hinge Health, Inc. alerts

New 13F filings, insider trades, and analyst moves on $HNGE, sent to your inbox. Free, and you can unsubscribe anytime.

This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.